Immulina as an Immunostimulatory Supplement: Formulation and Pharmacological Studies.
Immulina as an Immunostimulatory Supplement: Formulation and Pharmacological Studies.
复制标题
Immulina 作为免疫刺激补充剂:配方和药理学研究。
DOI:
10.1055/a-2156-4653
复制
发表时间:
2023
期刊:
影响因子:
2.7
通讯作者:
Tan,Chalet
中科院分区:
文献类型:
--
作者:
Li,Yusheng;Ji,Nan;Wang,Minia;Pugh,NirmalD;Khan,IkhlasA;Tan,Chalet
Immulina is a commercially available extract ofArthrospira platensisenriched with bacterial lipoproteins that acts as a potent Toll-like receptor 2 agonist. However, the immunostimulatory effect of Immulina is not well understoodin vivo. Here, to devise an Immulina formulation suitable forin vivooral gavage dosing, Immulina nanosuspension was prepared and freeze-dried to yield lyophilized nano-Immulina, which had an average particle size of around 300 nm and fully retained the bioactivity as a Toll-like receptor 2 agonist. Compared to the regular Immulina powder, lyophilized nano-Immulina notably accelerated the dissolution in aqueous media. Immulina nanosuspension was found to stimulate the production of proinflammatory cytokines in murine bone marrow-derived dendritic cells and macrophages. The immune response to Immulina was investigated in healthy mice by longitudinally monitoring the phagocytic activity of circulating neutrophils as a surrogate marker. Following daily oral ingestion of Immulina nanosuspension (10 mg/mouse/day), the phagocytic activity of circulating neutrophils was significantly elevated, suggesting an important mechanism for Immulina to enhance innate immunity.